Please sign in to follow a disease.
New magnesium membrane could boost dental implant success
NCT ID NCT06059898
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested a new magnesium membrane (NOVAMag) against a standard collagen membrane (Jason) for rebuilding jawbone in 106 people needing dental implants. The goal was to see if the magnesium membrane is as good at promoting bone growth. Researchers measured bone volume with X-rays and biopsies after six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bioresorbable magnesium membrane (NOVAMag)
- What this could lead to
- If successful, this could offer a stronger, fully resorbable option for rebuilding jawbone, potentially improving dental implant success.
- What could go wrong
- This is a completed early-stage comparison, not a large-scale trial. The magnesium membrane may not prove better than the existing collagen option, and individual healing varies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
106 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Eligible are healthy patients that have the need for at least one dental implant. Specific inclusion criteria are: Inclusion Criteria: 1. Obtained informed consent from the patient, patients voluntarily signing the informed consent form before study related actions including patient's acceptance of the scheduled program of clinical and radiographic analysis 2. The patient shall be at least 18 years of age, male or female and have passed cessation of growth 3. Patients asking for more than one dental implant and presenting one site with a healed site (class h1i, h2i; h3i, v1i, c1i, h1e, h2e, h3e, Cologne Classification of Alveolar Ridge Defects (CCARD) requiring a GBR procedure prior to implant placement. 4. The teeth at the implant site must have been extracted or lost at least 8 weeks before the date of bone augmentation (volumetrically healed site) Exclusion Criteria: Systemic exclusion criteria 1. Major systemic diseases (e.g. recent myocardial infarction, cerebrovascular accident or valvular prosthesis surgery, a poorly stabilized diabetes mellitus, severe hypertension, severe peripheral artery occlusive disease, malignancies, autoimmune diseases, or kidney diseases, untreated or uncontrolled periodontal disease, uncontrolled drug or alcohol abuse, uncontrolled psychiatric disorders) 2. Acute infectious diseases 3. Immunocompromised patients 4. Serious disturbances of bone metabolism and/or serious bone diseases of endocrine etiology 5. Due to judgement of the principal investigator: Medical conditions requiring prolonged use of steroids and/or on-going treatment with gluco- and mineralocorticoids and with agents affecting calcium metabolism (e.g. calcitonin), and/or anti-coagulative therapy 6. Previous or current use of antiresorptive medication (e.g. bisphosphonates) 7. Previous oral / maxillofacial radiotherapy 8. Heavy smoker (definition: \>10 cigarettes per day) 9. Currently pregnant or breastfeeding women 10. Health conditions, which do not permit the surgical treatment Local exclusion criteria 1. Acute local inflammation or untreated periodontitis 2. Insufficient oral hygiene 3. Regenerative periodontal treatment necessary adjacent to the planned study site of interest 4. Mucosal diseases or oral white or ulcerative lesions (e.g. lichen planus, leukoplakia) 5. History of head and neck irradiation therapy 6. Severe bruxism or clenching or other destructive habits 7. Previous socket preservation, GBR or guided tissue regeneration (GTR) treatment at the implant site 8. Infections in tissue and adjacent tissue of the planned implantation site 9. Known hypersensitivity to any of the trace elements 10. Edentulous cases
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ridge augmentation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Copenhagen University Hospital, Department of Oral & Maxillofacial Surgery
Copenhagen, 2100, Denmark
-
Medical University of Graz Department of Dental Medicine and Oral Health
Graz, 8010, Austria
-
Studio Tabanella
Roma, 00198, Italy
-
Studio medico odontoiatrico Papi Stp Srl
Roma, 00176, Italy
-
University of Vienna, Department of Oral Surgery
Vienna, 1090, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.